1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dimethylphenylpiperazinium iodide

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with dimethylphenylpiperazinium iodide in 2 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (dimethylphenylpiperazinium iodide)	Trials (dimethylphenylpiperazinium iodide)	Recent Studies (post-2010) (dimethylphenylpiperazinium iodide)
9,156	187	552	766	1	46

Protein Interaction Comparison

Protein	Taxonomy	1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)	dimethylphenylpiperazinium iodide (IC50)
DNA dC->dU-editing enzyme APOBEC-3G isoform 1	Homo sapiens (human)		2.62
DNA dC->dU-editing enzyme APOBEC-3A isoform a	Homo sapiens (human)		1.93

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beaulieu, MJ; Blanchet, MR; Cormier, Y; Daleau, P; Israël-Assayag, E	1
Beaulieu, MJ; Blanchet, MR; Cormier, Y; Ferland, C; Israël-Assayag, E; Langlois, A; Laviolette, M	1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dimethylphenylpiperazinium iodide

Article	Year
Dimethyphenylpiperazinium, a nicotinic receptor agonist, downregulates inflammation in monocytes/macrophages through PI3K and PLC chronic activation. American journal of physiology. Lung cellular and molecular physiology, 2006, Volume: 291, Issue:4 Topics: Anti-Inflammatory Agents; Calcium; Calcium Channel Blockers; Dimethylphenylpiperazinium Iodide; Enzyme Activation; Humans; Inositol 1,4,5-Trisphosphate; Intracellular Membranes; Lipopolysaccharides; Macrophages, Alveolar; Monocytes; Nicotinic Agonists; Phosphatidylinositol 3-Kinases; Platelet Activating Factor; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Type C Phospholipases	2006
Modulation of eosinophil activation in vitro by a nicotinic receptor agonist. Journal of leukocyte biology, 2007, Volume: 81, Issue:5 Topics: Arachidonic Acids; Calcium; Cell Movement; Chemokine CCL11; Chemokines, CC; Dimethylphenylpiperazinium Iodide; Dose-Response Relationship, Drug; Eosinophils; Gene Expression Profiling; Humans; In Vitro Techniques; Leukotriene C4; Matrix Metalloproteinase 9; Nicotinic Agonists; Platelet Activating Factor; Protein Subunits; Receptors, Nicotinic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2007

Article

Year

Dimethyphenylpiperazinium, a nicotinic receptor agonist, downregulates inflammation in monocytes/macrophages through PI3K and PLC chronic activation.

American journal of physiology. Lung cellular and molecular physiology, 2006, Volume: 291, Issue:4

Topics: Anti-Inflammatory Agents; Calcium; Calcium Channel Blockers; Dimethylphenylpiperazinium Iodide; Enzyme Activation; Humans; Inositol 1,4,5-Trisphosphate; Intracellular Membranes; Lipopolysaccharides; Macrophages, Alveolar; Monocytes; Nicotinic Agonists; Phosphatidylinositol 3-Kinases; Platelet Activating Factor; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Type C Phospholipases

2006

Modulation of eosinophil activation in vitro by a nicotinic receptor agonist.

Journal of leukocyte biology, 2007, Volume: 81, Issue:5

Topics: Arachidonic Acids; Calcium; Cell Movement; Chemokine CCL11; Chemokines, CC; Dimethylphenylpiperazinium Iodide; Dose-Response Relationship, Drug; Eosinophils; Gene Expression Profiling; Humans; In Vitro Techniques; Leukotriene C4; Matrix Metalloproteinase 9; Nicotinic Agonists; Platelet Activating Factor; Protein Subunits; Receptors, Nicotinic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2007